Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of sitagliptin as add-on therapy on glycemic control and blood glucose fluctuation in Japanese type 2 diabetes subjects ongoing with multiple daily insulin injections therapy

Published:2013 Issue:10 Volume:60 Page:1207-1214
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

Shimoda Seiya¹,Iwashita Shinsuke¹,Ichimori Shinji²,Matsuo Yasuto³,Goto Rieko¹,Maeda Takako¹,Matsuo Tomoko¹,Sekigami Taiji⁴,Kawashima Junji¹,Kondo Tatsuya¹,Matsumura Takeshi¹,Motoshima Hiroyuki¹,Furukawa Noboru¹,Nishida Kenro⁵,Araki Eiichi¹

Affiliation:

1. Department of Metabolic Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan

2. Ueki Hospital, Kumamoto 861-0136, Japan

3. Saiseikai Kumamoto Hospital, Kumamoto 861-4193, Japan

4. Kumamoto Social Insurance General Hospital, Yatsushiro 866-0856, Japan

5. Minamata City Hospital and Medical Center, Minamata 867-0041, Japan

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.jstage.jst.go.jp/article/endocrj/60/10/60_EJ13-0198/_pdf

Reference45 articles.

1. 1. Donner T, Muñoz M (2012) Update on insulin therapy for type 2 diabetes. J Clin Endocrinol Metab 97: 1405-1413.

2. 2. Testa MA, Gill J, Su M, Turner RR, Blonde L, et al. (2012) Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial. J Clin Endocrinol Metab 97: 3504-3514.

3. 3. Fritsche A, Larbig M, Owens D, Häring HU; GINGER study group (2010) Comparison between a basal-bolus and a premixed insulin regimen in individuals with type 2 diabetes-results of the GINGER study. Diabetes Obes Metab 12: 115-123.

4. 4. Giugliano D, Maiorino MI, Bellastella G, Chiodini P, Ceriello A, et al. (2011) Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials. Diabetes Care 34: 510-517.

5. 5. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, et al. (1995) Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 28: 103-117.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum vitamin B12 levels and glycemic fluctuation in patients with type 2 diabetes mellitus;Therapeutic Advances in Endocrinology and Metabolism;2022-01

2. Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus;Drug Delivery;2020-12-21

3. Dipeptidyl dipeptidase-4 inhibitor recovered ischemia through an increase in vasculogenic endothelial progenitor cells and regeneration-associated cells in diet-induced obese mice;PLOS ONE;2019-03-19

4. Dipeptidyl dipeptidase-4 inhibitor, MK-0626, promotes bone marrow-derived endothelial progenitor cell bioactivities for vascular regeneration in diet-induced obese mice;2018-09-27

5. Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia;Journal of Diabetes Investigation;2018-09-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3